Quick Answer
Serina Therapeutics, Inc. reported Net Income of -$19.18 million for fiscal year 2025.
Serina Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$19.18M | -72.2% |
| 2024 | -$11.14M | -311.4% |
| 2023 | $5.27M | +150.4% |
| 2022 | -$10.46M | -20.6% |
| 2021 | -$8.68M | +20.2% |
| 2020 | -$10.87M | -643.2% |
| 2020 | $2.00M | +116.5% |
| 2019 | -$12.15M | -62.0% |
| 2018 | -$7.50M | -14.0% |
| 2017 | -$6.58M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.58M | -425.2% | +28.9% |
| June 30, 2025 | -$6.45M | -223.9% | -34.0% |
| March 31, 2025 | -$4.81M | +67.9% | -441.3% |
| September 30, 2024 | $1.41M | -19.5% | -72.9% |
| June 30, 2024 | $5.20M | +544.1% | +134.7% |
| March 31, 2024 | -$15.02M | -1005.6% | -957.0% |
| September 30, 2023 | $1.75M | +172.0% | +116.8% |
| June 30, 2023 | $808.0K | +130.9% | -51.3% |
- Serina Therapeutics, Inc. showed a decrease of -72.2% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Serina Therapeutics, Inc.’s net income has declined by 191.5% (from -$6.58 million to -$19.18 million).
- The most recent figure is from Serina Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: